Modified Atkins diet ( DrugBank: - )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 145 | West syndrome | 1 |
| 157 | Sturge-Weber syndrome | 1 |
| 187 | Kabuki syndrome | 1 |
145. West syndrome
Clinical trials : 43 / Drugs : 52 - (DrugBank : 15) / Drug target genes : 28 - Drug target pathways : 26
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01006811 (ClinicalTrials.gov) | October 2009 | 1/11/2009 | Use of the Modified Atkins Diet in Infantile Spasms | Efficacy and Tolerability of the Modified Atkins Diet in Patients With Infantile Spasms: a Pilot Study. | Infantile Spasms | Dietary Supplement: modified Atkins diet;Other: modified Atkins diet | All India Institute of Medical Sciences, New Delhi | NULL | Completed | 6 Months | 3 Years | Both | 15 | Phase 2/Phase 3 | India |
157. Sturge-Weber syndrome
Clinical trials : 10 / Drugs : 13 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 63
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00639730 (ClinicalTrials.gov) | May 2006 | 14/3/2008 | Use of the Atkins Diet for Children With Sturge Weber Syndrome | Use of the Atkins Diet for Children With Sturge Weber Syndrome | Epilepsy;Sturge Weber Syndrome | Dietary Supplement: modified Atkins diet | Johns Hopkins University | Vascular Birthmarks Foundation | Completed | 2 Years | 18 Years | Both | 5 | Phase 1 | United States |
187. Kabuki syndrome
Clinical trials : 4 / Drugs : 9 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 11
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04722315 (ClinicalTrials.gov) | April 1, 2021 | 24/11/2020 | Study of Modified Atkins Diet in Kabuki Syndrome | Pilot Clinical Trial of Modified Atkins Diet for Kabuki Syndrome | Kabuki Syndrome | Dietary Supplement: Modified Atkins diet | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | NULL | Recruiting | 18 Years | N/A | All | 15 | Early Phase 1 | United States |